Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 08:00PM GMT
Release Date Price: €75 (+3.48%)
Travis Steed

Good afternoon, everybody. I am Travis Steed, medical device analyst at Barclays. And up next this afternoon, we're pleased to have Tandem Diabetes. John Sheridan, President and CEO; Leigh Vosseller, Executive Vice President and CFO; and Susan Morrison, is also joining us as well, Executive Vice President, Chief Administrative Officer and Head of Investor Relations. So welcome. I'm glad you could join us today virtually. Hopefully next year, we'll be in person in Miami.

So just wanted to start out some of the long term, you're one of the few companies that really had long-term guidance and kept long-term guidance through COVID. You've talked about 500,000 patients in 2024. And just trying to think about, how do you feel about that number today? And do you think more of that's going to come from the U.S. now that some of the international markets are potentially a bit more challenged with COVID?

And John, I think you're still on mute.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

How about that?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot